Clinical meaning
Coarctation of the aorta (CoA) is a congenital cardiovascular malformation characterized by a discrete narrowing (stenosis) of the thoracic aorta, most commonly located in the juxtaductal region -- just distal to the origin of the left subclavian artery at the site where the ductus arteriosus (ligamentum arteriosum after closure) inserts into the aortic isthmus. This anatomical localization is not coincidental: the ductal tissue theory proposes that ectopic ductal smooth muscle tissue extends into the aortic wall, and when the ductus arteriosus constricts during normal postnatal closure, this aberrant ductal tissue within the aortic wall also constricts, producing a localized shelf-like narrowing of the aortic lumen. CoA occurs in approximately 5-8% of all congenital heart defects, with an incidence of approximately 4 per 10,000 live births, and has a male predominance of approximately 2:1. It is strongly associated with Turner syndrome (45,X) -- CoA is present in 10-15% of patients with Turner syndrome, and all females with CoA should be evaluated for Turner syndrome with karyotype analysis. CoA frequently coexists with other cardiac anomalies, most notably bicuspid aortic valve (present in 50-75% of CoA patients -- the most common associated cardiac defect), ventricular septal defect (VSD), patent ductus arteriosus (PDA), mitral valve abnormalities (parachute mitral valve in Shone complex), and intracranial berry aneurysms (particularly in the Circle of Willis -- present in 2-10% of CoA patients, creating a risk of subarachnoid hemorrhage especially if hypertension is uncontrolled). The hemodynamic consequences of CoA are determined by the degree of aortic narrowing and the rapidity of its development. In severe coarctation presenting in the neonatal period, the narrowing is critical and the infant depends on the patent ductus arteriosus (PDA) to maintain lower body perfusion. Blood flows right-to-left through the PDA from the pulmonary artery to the descending aorta, bypassing the coarctation. When the PDA begins to close naturally in the first days of life, lower body perfusion drops precipitously, causing cardiogenic shock with metabolic acidosis, renal failure, necrotizing enterocolitis, and death if not treated emergently. This ductus-dependent circulation is the basis for prostaglandin E1 (alprostadil) therapy, which reopens and maintains ductal patency as a life-saving bridge to surgical repair. In older children and adults with less severe coarctation, the hemodynamic picture is dominated by upper body hypertension and lower body hypoperfusion. The narrowed aortic segment acts as a mechanical obstruction to blood flow, creating a pressure gradient between the aorta proximal to the coarctation (upper body -- head, arms) and the aorta distal to the coarctation (lower body -- abdomen, legs). This produces the pathognomonic finding of CoA: upper extremity hypertension with diminished or absent femoral pulses and lower extremity hypotension. The blood pressure differential between arms and legs is typically >20 mmHg systolic. The left ventricle faces increased afterload from the fixed obstruction, leading to concentric left ventricular hypertrophy. Over time, collateral circulation develops through intercostal arteries (branches of the subcostal, internal thoracic, and lateral thoracic arteries) that bypass the coarctation, connecting the pre-coarctation arterial system to the post-coarctation descending aorta. These enlarged, tortuous collateral arteries produce the classic rib notching seen on chest X-ray (bilateral notching of the inferior margins of the third through eighth ribs, caused by erosion of the undersurface of the ribs by dilated, pulsatile intercostal arteries). Another classic CXR finding is the 3-sign (figure-3 sign): the pre-stenotic aortic dilation above the coarctation, the indentation at the coarctation site, and the post-stenotic aortic dilation below the coarctation together create a figure-3 appearance. Even after successful surgical repair, patients with CoA have lifelong cardiovascular risk. Persistent hypertension occurs in 25-40% of patients after repair due to abnormal aortic wall compliance, altered baroreceptor function, and activation of the renin-angiotensin system from chronic renal hypoperfusion. Re-coarctation (recurrent narrowing at the repair site) occurs in 5-15% of patients, particularly those repaired in infancy. Aortic aneurysm formation can occur at the repair site or in the ascending aorta (associated with bicuspid aortic valve). Premature coronary artery disease and stroke risk are elevated. All patients require lifelong cardiovascular follow-up with serial blood pressure monitoring, echocardiography (to assess for re-coarctation, bicuspid aortic valve progression, and LV function), and screening for intracranial aneurysms. The nursing assessment is critical for detecting CoA, particularly in neonates. The single most important screening maneuver is simultaneous palpation of the right brachial and femoral pulses -- absent or diminished femoral pulses with bounding upper extremity pulses is the hallmark finding. Four-extremity blood pressure measurement reveals upper extremity systolic BP >20 mmHg higher than lower extremity BP. In neonates with critical coarctation, signs of cardiogenic shock develop as the PDA closes: tachycardia, tachypnea, poor feeding, lethargy, mottled or gray skin color, metabolic acidosis, oliguria, and cardiovascular collapse. Recognition of these signs and immediate initiation of prostaglandin E1 infusion is life-saving.